Chul-Woong Chung

This inventor holds 17 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Legochem Biosciences, Inc., Ligachem Biosciences Inc.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chul-Woong Chung. Retrieved from https://idiyas.com/inventor/chul-woong-chung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 4)

% Patents Active = 88.2

CIPO Patents = 2 (Patent Applications = 12)

EPO Patents = 2 (Patent Applications = 15)

Average Co-Inventor Count = 13.4

ph-index = 8

Forward Citations = 121(Granted Patents)

Company Filing History:

15 out of 25

Legochem Biosciences, Inc.

patents

2 out of 2

Ligachem Biosciences Inc.

patents

Years Active: 2018-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12398124 - Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the same (2025-08-26),

2. 12391690 - Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same (2025-08-19),

3. 11975076 - Antibody-drug conjugates comprising branched linkers and methods related thereto (2024-05-07),

4. 11654197 - Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the same (2023-05-23),

5. 11548883 - Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same (2023-01-10),

6. 11413353 - Conjugates comprising self-immolative groups and methods related thereto (2022-08-16),

7. 11173214 - Antibody-drug conjugates comprising branched linkers and methods related thereto (2021-11-16),

8. 11167040 - Conjugates comprising peptide groups and methods related thereto (2021-11-09),

9. 10980890 - Compounds comprising self-immolative group (2021-04-20),

10. 10961242 - Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same (2021-03-30),

11. 10383949 - Compounds comprising self-immolative group (2019-08-20),

12. 10273235 - Compositions and methods for inhibiting β-lactamase (2019-04-30),

13. 10183997 - Compositions and methods related to anti-CD19 antibody drug conjugates (2019-01-22),

14. 10118965 - Compositions and methods related to anti-EGFR antibody drug conjugates (2018-11-06),

15. 9993568 - Compounds comprising self-immolative group (2018-06-12),

Title: Chul-Woong Chung: Innovator in Pharmaceutical Chemistry

Introduction

Chul-Woong Chung is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 17 patents. His work primarily focuses on developing innovative compounds for therapeutic applications, particularly in the treatment of cancer and other serious health conditions.

Latest Patents

Chung's latest patents include a pyrrolobenzodiazepine dimer prodrug and a ligand-linker conjugate compound. This invention relates to a composition that is particularly useful as an anticancer drug. The compounds exhibit excellent stability in plasma and are designed to target proliferative diseases, maximizing drug efficacy while minimizing side effects. Another notable patent involves novel compounds as autotoxin inhibitors, aimed at treating conditions caused by autotaxin activation. These compounds are beneficial for a range of disorders, including cardiovascular issues, cancer, and inflammatory diseases.

Career Highlights

Throughout his career, Chul-Woong Chung has worked with several notable companies, including Legochem Biosciences, Inc. and Ligachem Biosciences Inc. His expertise in pharmaceutical development has positioned him as a key figure in the industry, contributing to advancements in drug formulation and therapeutic strategies.

Collaborations

Chung has collaborated with esteemed colleagues such as Yong Zu Kim and Jeiwook Chae. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Chul-Woong Chung's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and drug development.

Profile summary based on public USPTO records.